Cancer vaccines based on mRNA advance, despite US cuts Technology

Cancer vaccines based on mRNA advance, despite US cuts

CHICAGO:  Treatments based on the same mRNA technology that delivered COVID-19 vaccines ​to market in record time are showing lasting benefit against the deadly ​skin cancer melanoma and early promise in pancreatic and brain cancers once considered impervious to immune system assault. The apparent breakthroughs in cancer vaccines – deemed one of the fastest-growing segments […]